Cardio Buzz

8: Mercury, Seafood and Your Heart

Seafood is a classic heart-healthy food. It is part of the Mediterranean diet that can lower blood pressure. Fish consumption was shown in several studies to lower the risk of death in patients with coronary artery disease. Seafoods are traditionally low in saturated fats, rich in iron, iodine and in omega-3 fatty acids. But also seafoods contain Methyl mercury which is produced by microorganisms in water and soil, and accumulates in fish. Recently, many people choose to limit their seafood consumption because of fear of mercury exposure from seafood. Excessive mercury may adversely affect the nervous system in infants and pregnant ladies and lactating mothers should avoid exposure to mercury because of its effects on the fetus. So what should we do? Consume fish and seafood to get the benefits on the CV system or reduce or intake to avoid exposure to mercury?https://www.fda.gov/food/consumers/advice-about-eating-fish

7: CABG in a Nutshell!

Surgical revascularization “coronary bypass” known as CABG is the most commonly performed cardiac surgery procedure worldwide with roughly one million procedures annually. We have seen in previous episodes that Cardiac surgery community was not happy the latest ACC revascularization guidelines. However, these guidelines have got lots to say on the performance of cardiac surgery. Let’s see what the ACC/AHA guidelines recommend on the optimal performance of coronary bypass graft.Hi everyone my name is Hussain Hishmat I’m an Interventional cardiologist. Welcome to my podcast Cardio Buzz. We provide doctors and anyone who is interested in cardiology a brief and focused update of cardiology trials, products and guidelines. We are still continuing our episodes on ACC AHA guidelines on coronary Revascularization and this episode is about CABG.We will talk about the optimal performance of coronary bypass; the medical aspects and the surgical aspects all in 10 minutes. We will cover antiplatelets, choice of grafts, sternal wound infection, off pump, stroke prevention and other topics. 

6: Dr Hani Sabbour on 2022 Middle East Recommendations for Lipid Management.

The middle east is not only an area of diversity and brisk transformations, it is also a region where cardiovascular diseases are rampant. Traditional risk factors for atherosclerotic disease are more prevalent than most regions around the globe; In the middle east, one in five will have either diabetes, obesity, hypertension, or smoking. Dyslipidemia, which is a recognized cause of atherosclerosis, is even more common. That’s why I decided to shed some light on Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update published this month in Atherosclerosis journal.https://doi.org/10.1016/j.atherosclerosis.2021.11.022And there is no better than Dr Hani Sabbour to interview on this indispensable publication. Dr. Sabbour is a colleague and friend. He has six American Board Certifications: Internal Medicine, General cardiology, Electrophysiology, Advanced Heart failure and Transplant Cardiology, Echocardiography and Nuclear Cardiology. He is currently Staff Physician in Cleveland Clinic Abu Dhabi. He is a co-principal investigator in the Gulf Familial Hyperlipidemia Registry and naturally, he is one of the authors of this consensus clinical recommendation.

5: Ten Questions on Coronary Angioplasty. ACC AHA Updated Guidelines. Part 3

Fixing coronary blockade without opening the chest is an attractive option to patients and their families… No surprise, Percutaneous coronary intervention PCI growing steadily since 1980s. 4 million PCIs are performed annually round the globe. A market size of 10 billion dollars!! What’s the best practice in PCI? Access, Assessment, gadgets, adjunctive medications. Let’s see what does the ACC/AHA guidelines recommend….

4: The surgical clash! ACC AHA guidelines on Coronary Revascularization. Part 2

A big question in revascularization, surgical or percutaneous? In the last decade, advanced technology has granted PCI more of the surgical territories. But what does the evidence say on choosing CABG versus PCI? Let’s see what the new ACC AHA guidelines have to tell us.Why the surgical community refused to endorse these guidelines?

3: ACC AHA Updated Guidelines on Coronary Revascularization. Part 1

Coronary revascularization; the bread and butter of modern cardiology practice and it got new guidelines! Jointly issued by the American Heart Association, American College of cardiology and the sky, and also reviewed by American Association for Thoracic Surgery, the guideline document was published simultaneously in JACC and in circulation less than a month ago. Noteworthy that these are first guidelines on the topic in 10 years. Several practice-changing trials were published in the same period.  This long-waited document comes to replace or retire five guidelines partially or totally, not only 2011 PCI and CABG guidelines, but also will replace sections in STEMI guidelines, ACS guidelines and stable IHD guidelines. So this is a document not to miss!

2: FDA approves new cholesterol injection. Good news or is it too early to celebrate?

Big news this week. The FDA approves a new therapy for cholesterol lowering “inclisiran”.  So what is this new therapy? Why did the FDA approve it and to whom? What does it mean for patients and where does the new therapy stand among other similar lipid lowering drugs currently available?

1: The best heart failure recipe

Heart failure is like cancer. The mortality is high and the burden on the economy is huge. We have almost  dozen  medications to treat heart failure and most of them work. So what  combination of drugs  give the best effect in heart failure? A new research suggests a "fantastic four" approach to be the best. Listen here to know the answer!